The purpose of this study is to explore the expression level of Krm2 in gastric cancer and its relationship with patients’ pathological features to clarify the regulatory role of Krm2 in the development and metastasis of gastric cancer and to lay a foundation for the development of new therapeutic targets for gastric cancer. The gene discussed is KREMEN2; the disease is gastric cancer.